Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
255.00 CHF | -1.05% |
|
-0.82% | -0.20% |
07-14 | OraSure Technologies received takeover bid from industry entrepreneur, sources say | RE |
07-14 | ROCHE HOLDINGS AG : JP Morgan remains a Sell rating | ZD |
Projected Income Statement: Roche Holding AG
Annual
Quarterly
Halfyear
Annual
Quarterly
Halfyear
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 58,323 | 62,801 | 63,281 | 58,716 | 60,495 | 62,632 | 65,049 | 67,064 |
Change | - | 7.68% | 0.76% | -7.21% | 3.03% | 3.53% | 3.86% | 3.1% |
EBITDA 1 | 24,281 | 24,692 | 25,015 | 21,976 | 23,538 | 25,491 | 26,356 | 27,469 |
Change | - | 1.69% | 1.31% | -12.15% | 7.11% | 8.3% | 3.39% | 4.22% |
EBIT 1 | 21,536 | 21,897 | 22,173 | 19,240 | 20,823 | 22,228 | 23,081 | 24,238 |
Change | - | 1.68% | 1.26% | -13.23% | 8.23% | 6.75% | 3.84% | 5.01% |
Interest Paid 1 | -578 | -757 | -1,214 | -1,300 | -1,610 | -1,260 | -1,212 | -1,146 |
Earnings before Tax (EBT) 1 | 17,965 | 17,398 | 16,327 | 14,079 | 11,793 | 19,176 | 20,671 | 22,152 |
Change | - | -3.16% | -6.16% | -13.77% | -16.24% | 62.6% | 7.8% | 7.16% |
Net income 1 | 14,295 | 13,930 | 12,421 | 11,498 | 8,277 | 13,614 | 14,691 | 15,870 |
Change | - | -2.55% | -10.83% | -7.43% | -28.01% | 64.47% | 7.91% | 8.03% |
Announcement Date | 04/02/21 | 03/02/22 | 02/02/23 | 01/02/24 | 30/01/25 | - | - | - |
1CHF in Million
Estimates
Forecast Balance Sheet: Roche Holding AG
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 1,882 | 18,167 | 15,584 | 18,699 | 17,337 | 12,186 | 6,986 | 1,085 |
Change | - | 865.3% | -14.22% | 19.99% | -7.28% | -29.71% | -42.67% | -84.47% |
Announcement Date | 04/02/21 | 03/02/22 | 02/02/23 | 01/02/24 | 30/01/25 | - | - | - |
1CHF in Million
Estimates
Cash Flow Forecast: Roche Holding AG
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
CAPEX 1 | 3,528 | 3,693 | 3,449 | 3,742 | 3,529 | 3,932 | 4,074 | 4,195 |
Change | - | 4.68% | -6.61% | 8.5% | -5.69% | 11.41% | 3.63% | 2.97% |
Free Cash Flow (FCF) 1 | 10,943 | 15,691 | 13,041 | 11,288 | 15,336 | 15,006 | 16,172 | 16,852 |
Change | - | 43.39% | -16.89% | -13.44% | 35.86% | -2.15% | 7.77% | 4.2% |
Announcement Date | 04/02/21 | 03/02/22 | 02/02/23 | 01/02/24 | 30/01/25 | - | - | - |
1CHF in Million
Estimates
Forecast Financial Ratios: Roche Holding AG
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
EBITDA Margin (%) | 41.63% | 39.32% | 39.53% | 37.43% | 38.91% | 40.7% | 40.52% | 40.96% |
EBIT Margin (%) | 36.93% | 34.87% | 35.04% | 32.77% | 34.42% | 35.49% | 35.48% | 36.14% |
EBT Margin (%) | 30.8% | 27.7% | 25.8% | 23.98% | 19.49% | 30.62% | 31.78% | 33.03% |
Net margin (%) | 24.51% | 22.18% | 19.63% | 19.58% | 13.68% | 21.74% | 22.58% | 23.66% |
FCF margin (%) | 18.76% | 24.99% | 20.61% | 19.22% | 25.35% | 23.96% | 24.86% | 25.13% |
FCF / Net Income (%) | 76.55% | 112.64% | 104.99% | 98.17% | 185.28% | 110.23% | 110.08% | 106.18% |
Profitability | ||||||||
ROA | 19.59% | 19.09% | 18.18% | 16.71% | 15.69% | 13.61% | 13.71% | 13.49% |
ROE | 47.99% | 56.02% | 62.5% | 45.73% | 43.45% | 43.89% | 39.02% | 35.57% |
Financial Health | ||||||||
Leverage (Debt/EBITDA) | 0.08x | 0.74x | 0.62x | 0.85x | 0.74x | 0.48x | 0.27x | 0.04x |
Debt / Free cash flow | 0.17x | 1.16x | 1.2x | 1.66x | 1.13x | 0.81x | 0.43x | 0.06x |
Capital Intensity | ||||||||
CAPEX / Current Assets (%) | 6.05% | 5.88% | 5.45% | 6.37% | 5.83% | 6.28% | 6.26% | 6.26% |
CAPEX / EBITDA (%) | 14.53% | 14.96% | 13.79% | 17.03% | 14.99% | 15.42% | 15.46% | 15.27% |
CAPEX / FCF (%) | 32.24% | 23.54% | 26.45% | 33.15% | 23.01% | 26.2% | 25.19% | 24.9% |
Items per share | ||||||||
Cash flow per share 1 | 21.46 | 24.39 | 22.79 | 20.02 | 25.05 | 24.03 | 25.79 | 26.73 |
Change | - | 13.64% | -6.56% | -12.16% | 25.16% | -4.08% | 7.29% | 3.67% |
Dividend per Share 1 | 9.1 | 9.3 | 9.5 | 9.6 | 9.7 | 9.867 | 10.11 | 10.39 |
Change | - | 2.2% | 2.15% | 1.05% | 1.04% | 1.72% | 2.45% | 2.82% |
Book Value Per Share 1 | 42.5 | 28.81 | 35.03 | 41.37 | 45.09 | 47.65 | 56.56 | 65.59 |
Change | - | -32.22% | 21.58% | 18.12% | 8.98% | 5.68% | 18.7% | 15.96% |
EPS 1 | 16.52 | 16.2 | 15.37 | 14.31 | 10.31 | 18.14 | 19.61 | 21.08 |
Change | - | -1.94% | -5.12% | -6.9% | -27.95% | 75.98% | 8.11% | 7.5% |
Nbr of stocks (in thousands) | 854,642 | 800,952 | 800,579 | 798,652 | 796,789 | 795,401 | 795,401 | 795,401 |
Announcement Date | 04/02/21 | 03/02/22 | 02/02/23 | 01/02/24 | 30/01/25 | - | - | - |
1CHF
Estimates
2025 * | 2026 * | |
---|---|---|
P/E ratio | 14.2x | 13.1x |
PBR | 5.41x | 4.56x |
EV / Sales | 3.46x | 3.25x |
Yield | 3.83% | 3.92% |
More valuation ratios
* Estimated data
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Sell
Buy

Mean consensus
HOLD
Number of Analysts
20
Last Close Price
255.00CHF
Average target price
301.38CHF
Spread / Average Target
+18.19%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ROG Stock
- Financials Roche Holding AG
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition